Decode Ballistic Reports Like a Pro. Register Now!
LCI Learning

Share on Facebook

Share on Twitter

Share on LinkedIn

Share on Email

Share More

Grace White   13 August 2026

Read more at: https://www.lawyersclubindia.com/forum/create_message.asp

Armodafinil is a prescripttion drug that is used to improve wakefulness and reduce excessive daytime sleepiness in patients who suffer from certain types of sleep disorders. Armodafinil is indicated for treatment of narcolepsy, OSAHS and chronic shift work sleep disorder (SWSD) in Australia.

Patients who suffer from narcolepsy will benefit from use of armodafinil because it reduces the effects of excessive daytime sleepiness. If the patient suffers from OSAHS, then armodafinil can be combined with CPAP to improve their wakefulness, but it cannot help cure airway obstruction that causes this disorder. Patients who suffer from shift work sleep disorder might find it useful in maintaining their wakefulness during work shifts when other non-pharmacological approaches fail to work.

Armodafinil affects the central nervous system, but the exact mechanism of inducing wakefulness remains unknown. The strength of the armodafinil tablet is 50 mg, 150 mg and 250 mg in the Australian Nuvigil product information.

Conclusion: Armodafinil is mainly used to improve wakefulness in patients who suffer from particular sleep disorders.

https://www.armodafinil.com.au/product/artvigil-50-mg



Quick Summary
Armodafinil is a prescription medication approved in Australia for treating excessive daytime sleepiness associated with narcolepsy, obstructive sleep apnoea/hypopnoea syndrome (OSAHS), and shift work sleep disorder. While it enhances wakefulness, it's important to note that for OSAHS, it complements CPAP therapy rather than curing the underlying obstruction. For shift workers, it can be a helpful option when other methods fail.

 2 Replies

T. Kalaiselvan, Advocate (Advocate)     13 August 2026

Sorry, we don't entertain business promotion advertisements in this forum for any reason

Dr. J C Vashista (Advocate )     14 August 2026

Another useless advertisement on this platform.


Leave a reply

Your are not logged in . Please login to post replies

Click here to Login / Register